Lv41
788 积分 2022-04-18 加入
Triple knockdown of CD11a, CD49d, and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice
7小时前
待确认
Advanced gene editing technologies for oncology mechanisms, applications, and clinical implementation
1个月前
已完结
Bispecific and bifunctional single chain recombinant antibodies
1个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
2个月前
已完结
Chimeric antigen receptor-engineered (CAR)-T cell therapy for metastatic prostate cancer
2个月前
已完结
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
2个月前
已完结
How crosstalk at the immune synapse shapes T cell and dendritic cell biology
4个月前
已完结
Engineered T cells call for back-up
4个月前
已完结
T Cell-Redirecting Strategies to ‘STAb’ Tumors: Beyond CARs and Bispecific Antibodies
4个月前
已完结
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
5个月前
已完结
皖公网安备34019202002308
